Skip to main content
Caplight Logo









Neosoma, Inc.

Neosoma, Inc.

Private
Groton, MassachusettsHealthcare & Life Scienceshttps://www.neosomainc.com/

Last Round

Seed Round

Mar 27, 2026

Total Funding Raised

$2.18M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neosoma, Inc. is a medical technology company that provides an AI-based, cloud-native software platform for brain tumor analysis from MRI scans.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AIneuro-oncologySaMDtumor segmentationAI radiologysoftware as a medical devicevolumetric measurementradiology AIMRI analysisclinical decision supportPACS integrationbrain tumor trackingusage-based SaaSradiation treatment planningDICOM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neosoma, Inc. Comparables

Compare Neosoma, Inc. with similar companies based on industry and business-model similarity.

Neosoma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AFX Medical
84%
GE HealthCare Technologies Inc.
80%
Imaging Biometrics Limited
78%

Neosoma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 27, 2026
VC RoundJul 26, 2024
DebtSep 14, 2023
AngelNov 20, 2020

Key People

Founding team and executive leadership

Ken Kolodziej

CEO, Neosoma, Inc.

Executive Team

Neosoma, Inc. Investors

Notable investors and investment history

Neosoma, Inc. investors
InvestorRounds
Filter FundSeed Round, VC Round
Beacon AngelsDebt
Alliance of AngelsDebt, Seed Round
TCA Venture GroupDebt, Angel, Seed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2026

    Grew 33% QoQ from 9 to 12 employees.

Neosoma, Inc. Filings

Explore SEC and related filing metadata, where available.

Neosoma, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neosoma, Inc.'s valuation, stock price, and market status.

Is Neosoma, Inc. a public or private company?

Neosoma, Inc. is a private company.

What is the current stock price of Neosoma, Inc.?

Neosoma, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Neosoma, Inc. worth (valuation)?

Valuation information for Neosoma, Inc. is not publicly available.

Can I buy Neosoma, Inc. stock?

Neosoma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neosoma, Inc.'s last funding round?

Neosoma, Inc.'s most recent funding round was Seed Round on March 27, 2026.

Who are the main investors in Neosoma, Inc.?

Key investors in Neosoma, Inc. include Filter Fund.

Will Neosoma, Inc. IPO soon?

No public IPO plans have been announced for Neosoma, Inc..

How can I track Neosoma, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neosoma, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGroton, Massachusetts
Employee Range12
Year Founded2019
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?